Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chin B Eap

Showing results (51-60 of 179) with videos related to

Pageof 18
Sort By:
Revue Medicale Suisse|March 8, 2016
[New developments in psychiatry]Philippe Conus, Fabrice Herrera, Sylvie Berney, et al.
Journal of Child and Adolescent Psychopharmacology|January 4, 2018
Second-Generation Antipsychotics in Adolescent Psychiatric Patients: Metabolic Effects and Impact of an Early Weight Change to Predict Longer Term Weight GainFrederik Vandenberghe, Alexandra Najar-Giroud, Laurent Holzer, et al.
Therapeutic Advances in Psychopharmacology|December 20, 2019
Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patientsNicolas Ansermot, Meredith Bochatay, Jürg Schläpfer, et al.
Frontiers in Psychiatry|September 2, 2025
Childhood trauma and relationship with the parents: associations with lipids, glucose, and prolactin levels during antipsychotic treatment in patients with first-episode psychosisMarianne Laffely, Claire Grosu, Nermine Laaboub, et al.
Drug Safety|September 2, 2006
Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilanceEveline Jaquenoud Sirot, Jan Willem van der Velden, Katharina Rentsch, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 31, 2009
Validation and long-term evaluation of a modified on-line chiral analytical method for therapeutic drug monitoring of (R,S)-methadone in clinical samplesNicolas Ansermot, Serge Rudaz, Marlyse Brawand-Amey, et al.
Frontiers in Psychiatry|July 11, 2022
Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced ActivityVincent Guinchat, Nicolas Ansermot, Kuntheavy Ing Lorenzini, et al.
Clinical Pharmacokinetics|July 2, 2015
Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric CohortFrederik Vandenberghe, Monia Guidi, Eva Choong, et al.
Journal of Clinical Psychopharmacology|May 16, 2007
Increased (R)-methadone plasma concentrations by quetiapine in cytochrome P450s and ABCB1 genotyped patientsClaude Uehlinger, Séverine Crettol, Philippe Chassot, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 29, 2011
Quantification of 4 antidepressants and a metabolite by LC-MS for therapeutic drug monitoringEva Choong, Serge Rudaz, Astrid Kottelat, et al.
Pageof 18

Showing results (51-60 of 179) with videos related to

Sort By:
Pageof 18
Revue Medicale Suisse|March 8, 2016
[New developments in psychiatry]Philippe Conus, Fabrice Herrera, Sylvie Berney, et al.
Journal of Child and Adolescent Psychopharmacology|January 4, 2018
Second-Generation Antipsychotics in Adolescent Psychiatric Patients: Metabolic Effects and Impact of an Early Weight Change to Predict Longer Term Weight GainFrederik Vandenberghe, Alexandra Najar-Giroud, Laurent Holzer, et al.
Therapeutic Advances in Psychopharmacology|December 20, 2019
Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patientsNicolas Ansermot, Meredith Bochatay, Jürg Schläpfer, et al.
Frontiers in Psychiatry|September 2, 2025
Childhood trauma and relationship with the parents: associations with lipids, glucose, and prolactin levels during antipsychotic treatment in patients with first-episode psychosisMarianne Laffely, Claire Grosu, Nermine Laaboub, et al.
Drug Safety|September 2, 2006
Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilanceEveline Jaquenoud Sirot, Jan Willem van der Velden, Katharina Rentsch, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 31, 2009
Validation and long-term evaluation of a modified on-line chiral analytical method for therapeutic drug monitoring of (R,S)-methadone in clinical samplesNicolas Ansermot, Serge Rudaz, Marlyse Brawand-Amey, et al.
Frontiers in Psychiatry|July 11, 2022
Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced ActivityVincent Guinchat, Nicolas Ansermot, Kuntheavy Ing Lorenzini, et al.
Clinical Pharmacokinetics|July 2, 2015
Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric CohortFrederik Vandenberghe, Monia Guidi, Eva Choong, et al.
Journal of Clinical Psychopharmacology|May 16, 2007
Increased (R)-methadone plasma concentrations by quetiapine in cytochrome P450s and ABCB1 genotyped patientsClaude Uehlinger, Séverine Crettol, Philippe Chassot, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 29, 2011
Quantification of 4 antidepressants and a metabolite by LC-MS for therapeutic drug monitoringEva Choong, Serge Rudaz, Astrid Kottelat, et al.
Pageof 18